Shilpa Medicare Ltd. NSE: SHILPAMED | BSE: 530549

Strong Performer, Getting Expensive

Download real time

913.00 -19.85 (-2.13%)

64.50% Gain from 52W Low

35,091

NSE+BSE Volume

NSE 17 Jul, 2025 11:56 AM (IST)

US FDA Classification

Shilpa Medicare's Bengaluru facility gets US FDA's voluntary action indicated (VAI) classification See details

Shilpa Medicare Ltd. News and Updates

Name: Latest research reports of Shilpa Medicare Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Shilpa Medicare Ltd.
Rating: 3
Author: ICICI Securities Limited

Keep track of all breaking news on Shilpa Medicare Ltd. from all sources in a single place.

Load latest

Is Shilpa Medicare Ltd. worth buying?

246 Votes:

Buy 78.86%

Sell 11.79%

Hold 9.35%